Utili R, Rambaldi A, Tripodi M F, Andreana A
Institute of Medical Therapy, Faculty of Medicine, 2nd University of Naples, Italy.
Infection. 1995 May-Jun;23(3):182-3. doi: 10.1007/BF01793862.
Data on the efficacy and safety of pentavalent antimony in the treatment of visceral leishmaniasis during pregnancy are scanty. A case of visceral leishmaniasis in a 39-year-old woman in the second trimester of pregnancy is reported here. The patient was hospitalized in poor condition with high fever and pancytopenia which had lasted for 6 weeks. A bone marrow aspirate revealed numerous amastigotes and serodiagnosis for Leishmania was positive at a high titer. The patient was successfully treated with meglumine antimoniate at a daily dose of 850 mg of antimony for 20 days. She delivered at term a healthy female baby who remains in good condition at 18 months of age. Thus a dose of 850 mg of antimony, which is lower than that presently recommended, seems to be effective and non toxic to the fetus when administered at the second trimester of pregnancy.
关于五价锑在孕期治疗内脏利什曼病的疗效和安全性的数据很少。本文报告了一例39岁处于妊娠中期的女性内脏利什曼病病例。该患者病情严重,因高热和全血细胞减少住院,症状持续了6周。骨髓穿刺显示有大量无鞭毛体,利什曼原虫血清学诊断呈高滴度阳性。患者成功接受了葡甲胺锑酸盐治疗,每日剂量为850毫克锑,持续20天。她足月产下一名健康女婴,该女婴在18个月大时状况良好。因此,850毫克锑的剂量低于目前推荐剂量,在妊娠中期给药时似乎对胎儿有效且无毒。